Insulin resistance is not independently associated with chronic kidney disease in Chinese population: A population-based cross-sectional study

Clinica Chimica Acta

Volumn 448, Issue , 2015, Pages 232-237

  Jing, Ce ^a   Xu, Shaoyong ^a   Ming, Jie ^a   Cai, Jing ^a   Zhang, Rong ^a   Shen, Han ^a   Yang, Wenying ^b   Ji, Qiuhe ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Chinese adults; Chronic kidney disease; Epidemiology and outcomes; Insulin resistance; Metabolic syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CHINESE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT IN INSULIN RESISTANCE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; CHINA; CHRONIC KIDNEY FAILURE; COMPLICATION; HOMEOSTASIS; MULTIVARIATE ANALYSIS;

CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84937148800     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.07.013     Document Type: Article

References (29)

1. Zhang L., Wang F., Wang L., et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012, 379:815-822.
2. Nugent R.A., Fathima S.F., Feigl A.B., Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin. Pract. 2011, 118:c269-277.
3. Liao M.T., Sung C.C., Hung K.C., et al. Insulin resistance in patients with chronic kidney disease. J. Biomed. Biotechnol. 2012, 2012:691369.
4. Bodlaj G., Berg J., Pichler R., Biesenbach G. Prevalence, severity and predictors of HOMA-estimated insulin resistance in diabetic and nondiabetic patients with end-stage renal disease. J. Nephrol. 2006, 19:607-612.
5. Satirapoj B., Supasyndh O., Phantana-Angkul P., et al. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes. J. Med. Assoc. Thai. 2011, 94(Suppl. 4):S87-93.
6. Alberti K.G., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
7. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
8. Ming J., Xu S., Yang C., et al. Metabolic syndrome and chronic kidney disease in general Chinese adults: results from the 2007-08 China National Diabetes and Metabolic Disorders Study. Clin. Chim. Acta 2014, 430:115-120.
9. Johns B.R., Pao A.C., Kim S.H. Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals. Nephrol. Dial. Transplant. 2012, 27:1410-1415.
10. Basturk T., Unsal A. Is insulin resistance a risk factor for the progression of chronic kidney disease?. Kidney Blood Press. Res. 2011, 34:111-115.
11. Satirapoj B., Supasyndh O., Boonyavarakul A., Luesutthiviboon L., Choovichian P. The correlation of insulin resistance and renal function in non diabetic chronic kidney disease patients. J. Med. Assoc. Thail. 2005, 88(Suppl. 3):S97-104.
12. Pham H., Robinson-Cohen C., Biggs M.L., et al. Chronic kidney disease, insulin resistance, and incident diabetes in older adults. Clin. J. Am. Soc. Nephrol. 2012, 7:588-594.
13. Landau M., Kurella-Tamura M., Shlipak M.G., et al. Correlates of insulin resistance in older individuals with and without kidney disease. Nephrol. Dial. Transplant. 2011, 26:2814-2819.
14. Kobayashi S., Maesato K., Moriya H., Ohtake T., Ikeda T. Insulin resistance in patients with chronic kidney disease. Am. J. Kidney Dis. 2005, 45:275-280.
15. Chen J., Muntner P., Hamm L.L., et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J. Am. Soc. Nephrol. 2003, 14:469-477.
16. Park J.H., Oh S.W., Ahn S.Y., et al. Decreased estimated glomerular filtration rate is not directly related to increased insulin resistance. Diabetes Res. Clin. Pract. 2013, 99:366-371.
17. Jang C.M., Hyun Y.Y., Lee K.B., Kim H. Insulin resistance is associated with the development of albuminuria in Korean subjects without diabetes. Endocrine 2015, 48:203-210.
18. Yang W., Lu J., Weng J., et al. Prevalence of diabetes among men and women in China. N. Engl. J. Med. 2010, 362:1090-1101.
19. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
20. Ma Y.C., Zuo L., Chen J.H., et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J. Am. Soc. Nephrol. 2006, 17:2937-2944.
21. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002, 39:S1-266.
22. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998, 15:539-553.
23. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
24. Mykkanen L., Zaccaro D.J., Wagenknecht L.E., et al. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998, 47:793-800.
25. Ghaderian S.B., Hayati F., Shayanpour S., Beladi Mousavi S.S. Diabetes and end-stage renal disease; a review article on new concepts. J. Renal Inj. Prev. 2015, 4:28-33.
26. Keane W.F., Brenner B.M., de Zeeuw D., et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int. 2003, 63:1499-1507.
27. Brancati F.L., Whelton P.K., Randall B.L., et al. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 1997, 278:2069-2074.
28. Sheen Y.J., Sheu W.H. Metabolic syndrome and renal injury. Cardiol. Res. Pract. 2011, 2011:567389.
29. Hall M.E., do Carmo J.M., da Silva A.A., et al. Obesity, hypertension, and chronic kidney disease. Int. J. Nephrol. Renov. Dis. 2014, 7:75-88.